Literature DB >> 6607153

Pulmonary manifestations of the acquired immunodeficiency syndrome (AIDS).

C M Wollschlager, F A Khan, R K Chitkara, U Shivaram.   

Abstract

Fifteen patients with AIDS were hospitalized on the pulmonary service during the period from 1981 to 1983. We were impressed with the frequency and severity of lung involvement in these patients and evaluated them with respect to their pulmonary manifestations of AIDS. The 13 men and two women had a mean age of 32 years. Ten were active intravenous drug abusers with a mean drug use of 8.1 years. All presented with profound weight loss, ten with nonproductive cough, and eight with significant dyspnea. Fourteen of 15 patients had Pneumocystis carinii pneumonia (PCP) at the time of our evaluation. Chest radiographs in these 14 patients showed no uniform pattern which was predictive of PCP. However, all 13 patients tested had a widened alveolar arterial oxygen gradient (mean: 59 mm Hg) which correlated well with the presence of PCP. The most common pulmonary finding in our AIDS patients was infection: 14 had PCP which was readily diagnosed by transbronchial lung biopsy in eight patients, and five patients were found to have disseminated Mycobacterium avium-intracellulare which often developed after "recovery" from PCP. Therapy for PCP with trimethoprim/sulfamethoxazole (TMP/SMZ) was unsuccessful in eight of ten patients; four of these eight TMP/SMZ failures responded to pentamidine. Mortality was 100 percent in patients who had AIDS for more than one year, and 70 percent in those less than one year. Despite some symptomatic responses to therapy for pulmonary infections, the mortality in AIDS seems to be unaffected by appropriate therapy for the pulmonary manifestations of this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607153     DOI: 10.1378/chest.85.2.197

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Reexpansion pulmonary edema in AIDS.

Authors:  D H Libraty
Journal:  West J Med       Date:  1992-06

2.  Antimicrobial synergism against Mycobacterium avium complex strains isolated from patients with acquired immune deficiency syndrome.

Authors:  D M Yajko; J Kirihara; C Sanders; P Nassos; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  Therapeutic implications of inhibition versus killing of Mycobacterium avium complex by antimicrobial agents.

Authors:  D M Yajko; P S Nassos; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1987-01       Impact factor: 5.191

4.  Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages.

Authors:  C Perronne; A Gikas; C Truffot-Pernot; J Grosset; J J Pocidalo; J L Vilde
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 5.  Pediatric HIV infection: an imaging update.

Authors:  J O Haller; H L Cohen
Journal:  Pediatr Radiol       Date:  1994

Review 6.  Pulmonary complications of AIDS: a clinical strategy.

Authors:  J D Edelson; R H Hyland
Journal:  CMAJ       Date:  1989-06-01       Impact factor: 8.262

7.  Imaging lung manifestations of HIV/AIDS.

Authors:  Carolyn M Allen; Hamdan H Al-Jahdali; Klaus L Irion; Sarah Al Ghanem; Alaa Gouda; Ali Nawaz Khan
Journal:  Ann Thorac Med       Date:  2010-10       Impact factor: 2.219

8.  Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia.

Authors:  Ju-Yeon Cho; Dong-Min Kim; Yong Eun Kwon; Sung Ho Yoon; Seung Il Lee
Journal:  BMC Infect Dis       Date:  2009-10-18       Impact factor: 3.090

9.  Pneumocystis Jirovecii (carinii) pneumonia causing lung cystic lesions and pneumomediastinum in non-HIV infected patient.

Authors:  Hazim S Bukamur; Emhemmid Karem; Serag Fares; Mohammed Al-Ourani; Amro Al-Astal
Journal:  Respir Med Case Rep       Date:  2018-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.